Atypical neuroleptic risperidone modulates glial functions in C6 astroglial cells

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 1, 2009, Pages 11-15

  Quincozes Santos, André ^a   Bobermin, Larissa Daniele ^a   Kleinkauf Rocha, Juliana ^a   Souza, Diogo Onofre ^a   Riesgo, Rudimar ^b   Gonçalves, Carlos Alberto ^a   Gottfried, Carmem ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Astrocyte; Atypical neuroleptics; Autism; C6 cells; Risperidone

Indexed keywords

GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; GLUTATHIONE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; RISPERIDONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ARTICLE; ASTROCYTE; AUTISM; CELL FUNCTION; CONTROLLED STUDY; ENZYME ACTIVITY; NEUROPROTECTION; NONHUMAN; SOCIAL BEHAVIOR;

ANIMALS; ANTIPSYCHOTIC AGENTS; ASTROCYTES; CELL LINE, TUMOR; CELLS, CULTURED; GLUTAMATE-AMMONIA LIGASE; GLUTAMIC ACID; GLUTATHIONE; NITRIC OXIDE; RATS; REACTIVE OXYGEN SPECIES; RISPERIDONE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 58149349719     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.08.023     Document Type: Article

References (39)

1. Aitken K.J. Intersubjectivity, affective neuroscience, and the neurobiology of autistic spectrum disorders: a systematic review. Keio J Med 57 (2008) 15-36
2. Basta-Kaim A., Budziszewska B., Jaworska-Feil L., Tetich M., Kubera M., Leskiewicz M., et al. Antipsychotic drugs inhibit the human corticotropin-releasing-hormone gene promoter activity in neuro-2A cells-an involvement of protein kinases. Neuropsychopharmacology 31 (2006) 853-865
3. Benda P., Lightbody J., Sato G., Levine L., and Sweet W. Differentiated rat glial cell strain in tissue culture. Science 161 (1968) 370-371
4. Browne R.W., and Armstrong D. Reduced glutathione and glutathione disulfide. Methods Mol Biol 108 (1998) 347-352
5. Carlson C.D., Cavazzoni P.A., Berg P.H., Wei H., Beasley C.M., and Kane J.M. An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine. J Clin Psychiatry 64 (2003) 898-906
6. Chen Y., and Swanson R.A. Astrocytes and brain injury. J Cereb Blood Flow Metab 23 (2003) 137-149
7. Danbolt N.C. Glutamate uptake. Prog Neurobiol 65 (2001) 1-105
8. de Almeida L.M., Pineiro C.C., Leite M.C., Brolese G., Tramontina F., Feoli A.M., et al. Resveratrol increases glutamate uptake, glutathione content, and S100B secretion in cortical astrocyte cultures. Cell Mol Neurobiol 27 (2007) 661-668
9. dos Santos A.Q., Nardin P., Funchal C., de Almeida L.M., Jacques-Silva M.C., Wofchuk S.T., et al. Resveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cells. Arch Biochem Biophys 453 (2006) 161-167
10. Dringen R. Metabolism and functions of glutathione in brain. Prog Neurobiol 62 (2000) 649-671
11. Esterbauer H., and Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186 (1990) 407-421
12. Funchal C., Dos Santos A.Q., Jacques-Silva M.C., Zamoner A., Gottfried C., Wajner M., et al. Branched-chain alpha-keto acids accumulating in maple syrup urine disease induce reorganization of phosphorylated GFAP in C6-glioma cells. Metab Brain Dis 20 (2005) 205-217
13. Gottfried C., Tramontina F., Goncalves D., Goncalves C.A., Moriguchi E., Dias R.D., et al. Glutamate uptake in cultured astrocytes depends on age: a study about the effect of guanosine and the sensitivity to oxidative stress induced by H(2)O(2). Mech Ageing Dev 123 (2002) 1333-1340
14. Harvey B.H., and Nel A. Role of aging and striatal nitric oxide synthase activity in an animal model of tardive dyskinesia. Brain Res Bull 61 (2003) 407-416
15. Horrigan J.P., and Barnhill L.J. Risperidone and explosive aggressive autism. J Autism Dev Disord 27 (1997) 313-323
16. Hu J., Castets F., Guevara J.L., and Van Eldik L.J. S100 beta stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J Biol Chem 271 (1996) 2543-2547
17. Huang M.Z., Shentu J.Z., Chen J.C., Liu J., and Zhou H.L. Determination of risperidone in human plasma by HPLC-MS/MS and its application to a pharmacokinetic study in Chinese volunteers. J Zhejiang Univ Sci B 9 (2008) 114-120
18. Hussman J.P. Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism. J Autism Dev Disord 31 (2001) 247-248
19. Kapur J., Haas K.F., and Macdonald R.L. Physiological properties of GABAA receptors from acutely dissociated rat dentate granule cells. J Neurophysiol 81 (1999) 2464-2471
20. King B.H., and Bostic J.Q. An update on pharmacologic treatments for autism spectrum disorders. Child Adolesc Psychiatr Clin N Am 15 (2006) 161-175
21. Leysen J.E., Gommeren W., Janssen P.F., Van Gompel P., and Janssen P.A. Receptor interactions of dopamine and serotonin antagonists: binding in vitro and in vivo and receptor regulation. Psychopharmacol Ser 5 (1988) 12-26
22. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
23. Malone R.P., Sheikh R., and Zito J.M. Novel antipsychotic medications in the treatment of children and adolescents. Psychiatr Serv 50 (1999) 171-174
24. Mangoura D., Sakellaridis N., Jones J., and Vernadakis A. Early and late passage C-6 glial cell growth: similarities with primary glial cells in culture. Neurochem Res 14 (1989) 941-947
25. Minshew N.J., and Williams D.L. The new neurobiology of autism: cortex, connectivity, and neuronal organization. Arch Neurol 64 (2007) 945-950
26. Nel A., and Harvey B.H. Haloperidol-induced dyskinesia is associated with striatal NO synthase suppression: reversal with olanzapine. Behav Pharmacol 14 (2003) 251-255
27. Owens D.G. Extrapyramidal side effects and tolerability of risperidone: a review. J Clin Psychiatry 55 (1994) 29-35 Suppl
28. Parikh V., Khan M.M., and Mahadik S.P. Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J Psychiatr Res 37 (2003) 43-51
29. Parker K.K., Norenberg M.D., and Vernadakis A. "Transdifferentiation" of C6 glial cells in culture. Science 208 (1980) 179-181
30. Pillai A., Parikh V., Terry Jr. A.V., and Mahadik S.P. Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J Psychiatr Res 41 (2007) 372-386
31. Quincozes-Santos A., Abib R.T., Leite M.C., Bobermin D., Bambini-Junior V., Goncalves C.A., et al. Effect of the atypical neuroleptic risperidone on morphology and S100B secretion in C6 astroglial lineage cells. Mol Cell Biochem 314 (2008) 59-63
32. Quincozes-Santos A., Andreazza A.C., Nardin P., Funchal C., Goncalves C.A., and Gottfried C. Resveratrol attenuates oxidative-induced DNA damage in C6 Glioma cells. Neurotoxicology 28 (2007) 886-891
33. Reuss B., and Unsicker K. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes. Mol Cell Neurosci 18 (2001) 197-209
34. Rothermundt M., Ponath G., and Arolt V. S100B in schizophrenic psychosis. Int Rev Neurobiol 59 (2004) 445-470
35. Schneider T., and Przewlocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 30 (2005) 80-89
36. Scott L.J., and Dhillon S. Risperidone: a review of its use in the treatment of irritability associated with autistic disorder in children and adolescents. Paediatr Drugs 9 (2007) 343-354
37. Tordjman S., Drapier D., Bonnot O., Graignic R., Fortes S., Cohen D., et al. Animal models relevant to schizophrenia and autism: validity and limitations. Behav Genet 37 (2007) 61-78
38. Tort A.B., Souza D.O., and Lara D.R. Theoretical insights into the mechanism of action of atypical antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry 30 (2006) 541-548
39. Zarate Jr. C.A., Singh J., and Manji H.K. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry 59 (2006) 1006-1020